image

The best stocks to buy since 1993

Latest issue now available

Supreme - Launches digital vitamin brand

August 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SUP
  • Price:
  • 200p
Maiden results were ahead of expectations set at the IPO with sales +33% at £122m and profit +22% at £16.4m. Speaking to chief executive Sandy Chadha and finance director Suzanne Smith, my first question was why central costs had also climbed £3m year-on-year; after all, this is a business with  “high capital velocity” - a small amount of investment goes a long way in growing sales. Smith says that of the £3m, roughly £1.5m is direct costs (such as carriage, freight, etc) but the other £1.5m is made up of additional board members, additional investment in building its Direct to Customer (DTC) capability with an online distribution centre and dedicated staff, and consultancy ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe